We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sends Warning Letter After Investigation of Pediatric Illnesses
FDA Sends Warning Letter After Investigation of Pediatric Illnesses
Sentara Enterprises has received a letter from the FDA after an inspection of its facility in response to information from the Virginia Department of Health on two cases of illness in pediatric patients who were given Sentara products.